# Reading more of a DNA change's consequences

AlphaGenome is a unified DNA-sequence model that takes up to 1 Mb of DNA and predicts thousands of functional genomic tracks, including gene expression, splicing, chromatin features, transcription-factor binding, and contact maps.

Canonical: https://brightaifuture.com/discoveries/alphagenome-variant-effects
Format: discovery
Source publication: 2026-01-28
Bright publication: 2026-09-07
Substantive update: None recorded
Evidence and review: Demonstrated; confidence: unassessed; approved; ai-assisted. AI-assisted editorial comparison with the cited primary source; result, setting, source date and limitations retained. Independently checked within the research team. Publication authorized by the site owner; no human source review is claimed.

## The human problem

Most observed human genetic variation is non-coding, and interpreting its possible biological effects remains difficult.

## The prior constraint

Existing sequence-to-function methods traded off input sequence length against prediction resolution and often covered only selected biological modalities.

## AI’s actual role

A deep-learning model jointly predicts many molecular genomic measurements and scores the likely effect of a sequence variant across those modalities.

## The documented result

In the paper's external variant-effect evaluations, AlphaGenome matched or exceeded the strongest available external models in 25 of 26 evaluations; it also recapitulated mechanisms of clinically relevant variants near the TAL1 oncogene.

## Why it may matter

Researchers may be able to generate more integrated hypotheses about how a DNA variant changes gene regulation.

## Limitations

The model predicts molecular effects; it does not diagnose a patient, establish causal disease mechanisms, or prove a treatment works.

Training and evaluation draw on existing human and mouse experimental datasets.

The paper describes non-commercial API access, not universal clinical availability.

## Unresolved questions

Which predictions validate in disease-relevant tissues and individuals?

Can use of the model improve rare-disease interpretation or therapeutic development prospectively?

## Provenance and history

{
  "dates": {
    "eventDate": null,
    "publicationDate": "2026-01-28",
    "captureDate": "2026-09-07",
    "lastReviewedDate": "2026-09-07"
  },
  "provenance": {
    "origin": "editorial",
    "externalId": "https://www.nature.com/articles/s41586-025-10014-0"
  },
  "revisions": [
    {
      "id": "revision:4f2db3c0f9fa34cbf68e",
      "recordedAt": "2026-09-07",
      "summary": "Researchers may be able to generate more integrated hypotheses about how a DNA variant changes gene regulation.",
      "sourceIds": [
        "source-alphagenome-variant-effects"
      ]
    }
  ],
  "corrections": []
}

## Original sources

- [Advancing regulatory variant effect prediction with AlphaGenome](https://www.nature.com/articles/s41586-025-10014-0)

## Continue exploring

- [Health & biology](https://brightaifuture.com/worlds/health)
- [Frontier](https://brightaifuture.com/worlds/frontier)
- [What becomes possible when we can see and shape life’s machinery?](https://brightaifuture.com/threads/biology)
- [Where can human judgment go with a new instrument?](https://brightaifuture.com/threads/discovery)